The alliance, originally announced in November 2023, combines Almirall’s dermatological capabilities with Absci’s Integrated ...

The UK government has published its 10-Year Health Plan for England, which will see millions of patients being treated and ...

Ianalumab has a dual mechanism of action, B-cell depletion and BAFF-R inhibition, and is being investigated across various B ...

But here’s a question: have you, or a friend, or a family member, felt overwhelmed trying to sift through vast amounts of ...

Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the ...

Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual ...

Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...

I recently discussed this subject with Aidan Metzinger, Senior Director, Pfizer Marketing Excellence & Academy, who agrees: ...

The US Food and Drug Administration (FDA) has approved Celltrion’s intravenous (IV) formulation of Avtozma (tocilizumab-anoh) ...

Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered ...

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi ...

The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial ...